(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -32.54%18.48B | -33.12%12.94B | -30.90%6.96B | -41.06%34.26B | -40.17%27.4B | --19.35B | --10.08B | -6.01%58.12B | -0.45%45.8B | 18.81%61.83B |
Operating income | -32.54%18.48B | -33.12%12.94B | -30.90%6.96B | -41.06%34.26B | -40.17%27.4B | 19.35B | 10.08B | -6.01%58.12B | -0.45%45.8B | 18.81%61.83B |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Selling expenses | 48.64%-4.04B | 48.12%-2.89B | 49.90%-1.52B | 37.38%-9.87B | 34.77%-7.86B | ---5.57B | ---3.03B | 12.43%-15.76B | 8.42%-12.05B | -1.01%-17.99B |
Administrative expenses | 16.49%-1.46B | 20.51%-993.2M | 36.18%-482.5M | 18.56%-2.3B | 15.89%-1.75B | ---1.25B | ---756.07M | 20.49%-2.83B | 19.66%-2.08B | -19.62%-3.56B |
Impairment and provision | 4.81%-8.69B | 11.55%-5.42B | 8.63%-2.86B | 25.03%-12.73B | 14.76%-9.13B | ---6.13B | ---3.13B | -119.22%-16.98B | -136.87%-10.71B | -154.56%-7.74B |
-Other impairment is provision | 4.81%-8.69B | 11.55%-5.42B | 8.63%-2.86B | 25.03%-12.73B | 14.76%-9.13B | ---6.13B | ---3.13B | -119.22%-16.98B | -136.87%-10.71B | -154.56%-7.74B |
Special items of operating profit | 13.74%-4.8B | 4.54%-3.48B | 14.04%-1.6B | 12.09%-7.3B | 15.73%-5.56B | ---3.65B | ---1.86B | -1.92%-8.3B | -11.02%-6.6B | -9.45%-8.14B |
Operating profit | -116.30%-504.68M | -94.40%154.18M | -61.21%505.42M | -85.55%2.06B | -78.44%3.1B | 2.75B | 1.3B | -41.58%14.25B | -27.46%14.35B | 17.43%24.4B |
Financing cost | 64.06%-130.9M | 77.98%-71.41M | 69.17%-58.16M | 66.58%-414.02M | 50.64%-364.25M | ---324.29M | ---188.64M | -24.46%-1.24B | -1.35%-737.95M | 65.26%-995.52M |
Earning before tax | -123.27%-635.58M | -96.59%82.78M | -59.86%447.26M | -87.36%1.65B | -79.94%2.73B | 2.43B | 1.11B | -44.39%13.01B | -28.56%13.62B | 30.66%23.4B |
Tax | -90.86%-1.65B | -137.40%-1.64B | -234.48%-1.28B | 85.59%-610.63M | 78.58%-864.29M | ---691.97M | ---381.86M | 36.66%-4.24B | 23.10%-4.04B | -18.78%-6.69B |
After-tax profit from continuing operations | -222.40%-2.29B | -189.86%-1.56B | -213.33%-829.96M | -88.21%1.03B | -80.51%1.87B | 1.74B | 732.37M | -47.48%8.78B | -30.64%9.58B | 36.11%16.71B |
Earning after tax | -222.40%-2.29B | -189.86%-1.56B | -213.33%-829.96M | -88.21%1.03B | -80.51%1.87B | 1.74B | 732.37M | -47.48%8.78B | -30.64%9.58B | 36.11%16.71B |
Minority profit | 85.59%252.14M | 3.97%102.58M | -32.94%40.5M | 95.09%147.62M | 104.87%135.86M | --98.66M | --60.39M | 179.39%75.67M | 177.53%66.31M | -22.40%-95.32M |
Profit attributable to shareholders | -246.57%-2.54B | -201.54%-1.66B | -229.54%-870.46M | -89.81%886.87M | -81.81%1.73B | 1.64B | 671.98M | -48.23%8.7B | -31.54%9.51B | 36.02%16.8B |
Basic earnings per share | -231.13%-1.98 | -201.40%-1.45 | -228.81%-0.76 | -89.87%0.77 | -81.83%1.51 | 1.43 | 0.59 | -46.55%7.6 | -28.91%8.31 | 27.08%14.22 |
Diluted earnings per share | -231.13%-1.98 | -201.40%-1.45 | -228.81%-0.76 | -89.84%0.77 | -81.05%1.51 | 1.43 | 0.59 | -43.35%7.58 | -26.95%7.97 | 20.54%13.38 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data